abstract |
The present invention relates to compositions and methods comprising a T cell genetically modified to express a CAR and a SMAC mimetic for treating a patient having a disease, a disorder or a condition associated with an elevated expression of an antigen. In some embodiments, the antigen is a tumor antigen. |